Home / Recalls / RLC Labs Inc. / D-1617-2020

D-1617-2020 Class I Terminated

Recalled by RLC Labs Inc. — Phoenix, AZ

Recall Details

Product Type
Drugs
Report Date
September 23, 2020
Initiation Date
August 25, 2020
Termination Date
November 8, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
N/A

Product Description

Nature Throid, 1.25 Grain (81.25 mg) Thyroid USP [Liothyronine (T3) 11.25 mcg, Levothyroxine (T4) 47.5 mcg], 100-count bottles, Rx only, Manufactured by: RLC Labs Phoenix, AZ 85024, NDC 64727-3303-1

Reason for Recall

Subpotent Drug: FDA analysis found product to be subpotent

Distribution Pattern

Nationwide in the United States

Code Information

Lot #: 109032, Exp. Date 10/2022

Other recalls by RLC Labs Inc.

  • D-1596-2020 Class II — Nature-Throid, Thyroid USP [liothyronine (T3) 9 mcg and levothyroxine (T4) 38 mc (August 25, 2020)
  • D-1612-2020 Class II — WP Thyroid, Westhroid Pure, 1.75 Grain (113.75 mg) Thyroid USP, packaged in a) 1 (August 25, 2020)
  • D-1609-2020 Class II — WP Thyroid, Westhroid Pure, 1 Grain (65 mg) Thyroid USP, packaged in a) 1,000 Ta (August 25, 2020)
  • D-1614-2020 Class I — WP Thyroid, Westhroid Pure, 1/2 Grain (32.5 mg) Thyroid USP [Liothyronine (T3) 4 (August 25, 2020)
  • D-1607-2020 Class II — WP Thyroid, Westhroid Pure, 1/2 Grain (32.5 mg) Thyroid USP packaged in a) 1,000 (August 25, 2020)
  • D-1601-2020 Class II — Nature-Throid, Thyroid USP [liothyronine (T3) 15.75 mcg and levothyroxine (T4) 6 (August 25, 2020)
  • D-1602-2020 Class II — Nature-Throid, Thyroid USP [liothyronine (T3) 18 mcg and levothyroxine (T4) 76 m (August 25, 2020)
  • D-1605-2020 Class II — Nature-Throid, Thyroid USP [liothyronine (T3) 27 mcg and levothyroxine (T4) 114 (August 25, 2020)
  • D-1608-2020 Class II — WP Thyroid, Westhroid Pure, 3/4 Grain (48.75 mg) Thyroid USP, packaged in a) 1,0 (August 25, 2020)
  • D-1598-2020 Class II — Nature-Throid, Thyroid USP [liothyronine (T3) 4.5 mcg and levothyroxine (T4) 19 (August 25, 2020)